WHARF
Homewood, Alabama, 35209, United States
NCT Number: NCT05410600
The smart trainer ergometer is comprised of an ergometer with foot and hand pedals, and a visual display in front of the user that can show a variety of scenic pathways. The purpose of this study is to examine changes in power output, oxygen consumption, cognitive function, and quality of life after 8 weeks of smart trainer arm ergometry exercise training among individuals with post-stroke limb impairment.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Not applicable
Homewood, Alabama, 35209, United States
Individuals with physical disabilities show much lower rates of exercise participation than their able-bodied peers. Much of the reason for the low rates of activity among this population comes from the presence of barriers. Lack of motivation, lack of transportation, lack of accessible facilities and equipment, and cost are all factors that discourage exercise participation among those with disabilities. Based on these factors, there is a need for accessible enjoyable exercise options for people with physical disabilities. The smart trainer ergometer (also known as the Advanced Virtual Exercise Environment Device) is comprised of an ergometer with foot and hand pedals, and a visual display in front of the user that can show a variety of scenic pathways.
In our previous protocol (IRB-300001384) we explored the power output curves of people post stroke compared with non-impaired individuals during one arm versus two arm cycling exercise using the smart trainer arm ergometer. The work demonstrated the potential benefit of interactive exercise for those with physical disabilities. The purpose of this study is to examine changes in power output, oxygen consumption, cognitive function, and quality of life after 8 weeks of smart trainer arm ergometry exercise training among individuals who have a stroke-based limb impairment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Arm ergometer exercise training using the smart trainer.
Time frame: 8 weeks
Oxygen consumption (VO2) as measured during a graded exercise test using a portable metabolic system
Time frame: 8 weeks
NIH Stroke Scale Test. Scores range from 0 to 42. A higher score indicates greater functional impairment.
Time frame: 8 weeks
Mini-Mental State Exam. Scores range from 0 to 30, scores of 26 or higher indicate normal cognitive function
Time frame: 8 weeks
Stroke Impact Scale. Scores range from 0 to 100, with higher scores indicating higher quality of life.
Time frame: 8 weeks
Fatigue Severity Scale. Scores range from 9 to 63, with higher scores indicating greater fatigue severity.
Time frame: 8 weeks
Grip strength as measured using a hand dynamometer
Time frame: 8 weeks
System Usability Scale. Scores range from 0 to 100. Scores above 68 indicate above average usability. Scores below 68 point to issues with the design that need to be researched and resolved, while scores higher than 68 indicate the need for minor improvements to the design.
Time frame: 8 weeks
Semi-structured interview to capture participant feedback regarding the smart trainer exercise training program and ergometer.
University of Alabama at Birmingham
Other
Smart Trainer Arm Ergometry Exercise Training in Individuals Post-Stroke (RERC on Technologies to Promote Exercise and Health Among People With Disabilities)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT07276477
Behavior, Brain Diseases
Uşak, Turkey (Türkiye)
View Trial DetailsNCT06597929
Behavior, Brain Diseases
Barcelona, Catalonia, Spain
View Trial DetailsNCT04238260
Behavior, Brain Diseases
Vancouver, British Columbia, Canada
View Trial Details